Imaging-based Phenotypic Screening is a extremely powerful and flexible approach to drug discovery and pre-clinical research.
Learn how imaging-based phenotypic assays work and what kind of information you can expect from working with us.
WHAT ARE SOME OF THE CHALLENGES ASSOCIATED WITH PHENOTYPIC ASSAYS?
Data volume from imaging-based phenotypic assays can be overwhelming, especially for scientists new to imaging-based PDD and for non-biologists that may be unfamiliar with complex systems. At Phenovista we work collaboratively with you to identify the most relevant readouts using your scientific focus combined with our experience and optimization algorithms. This means that we deliver the most relevant and robust data in a format that can be easily communicated to other members of your team and management.
Phenotypic assays that use imaging, specifically automated quantitative fluorescence microscopy or high content screening (HCS), bring their own set of challenges. We’ve tried to address how we tackle these challenges but if you have other concerns please contact us.